免疫測定自動分析装置市場：製品、用途、エンドユーザー別-2025-2030年の世界予測

免疫測定自動分析装置市場は、2023年に118億2,000万米ドルと評価され、2024年には126億3,000万米ドルに達すると予測され、CAGR 6.92%で成長し、2030年には188億9,000万米ドルに達すると予測されています。

免疫測定自動分析装置は、イムノアッセイ技術によってサンプル内の特定の生体分子または分析物の検出と定量を自動化するように設計された高度な装置です。その必要性は、臨床検査、製薬、バイオテクノロジーなどの分野において、ハイスループットで正確かつ迅速な診断結果が求められていることに起因します。主な用途は疾病診断、薬剤モニタリング、がんバイオマーカー検出など多岐にわたり、主なエンドユーザーは病院、研究機関、診断研究所などです。市場成長の原動力は、技術の進歩、慢性疾患の増加、効率改善とエラー削減を目的とした検査室での自動化導入の増加です。ビジネスチャンスは、新興市場、個別化医療、データ解釈の改善のためのAIとの統合にあります。企業は、分析装置のスループット、感度、統合機能を強化するイノベーションを促進することで、これらを活用することができます。しかし、初期投資コストの高さ、厳しい規制、高度に熟練した人材の必要性などの課題が、市場拡大の妨げになる可能性があります。知的財産権の問題や、分子診断のような代替診断法との競合も脅威となります。検査パラメーターを広げるためのアッセイ開発や、ポイント・オブ・ケアに対応するための装置の小型化といった技術革新は、業界にとって有益です。さらに、費用対効果の高い多機能分析装置の調査により、市場浸透の新たな道が開ける可能性があります。自動免疫測定市場は、急速な技術革新、市場競争、患者転帰の改善を求める動きによって特徴づけられるダイナミックな性質を示します。そのため、競争優位性を維持するためには、研究開発への継続的な取り組み、戦略的パートナーシップ、規制当局の承認取得が重要です。企業はまた、ラボのインフラが発展し、ヘルスケア支出の増加とともに消費者基盤が急成長している新興国への地理的な足跡の拡大にも注力すべきです。これらの分野に取り組むことで、自動免疫測定器セクターの企業は課題を克服し、成長機会を得ることができます。

市場力学：急速に進化する免疫測定自動分析装置市場の主要市場インサイトを公開

免疫測定自動分析装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の慢性疾患および感染症の流行拡大
  • 臨床検査自動化への急速なシフト
  • 早期診断と治療に対する意識の高まり
• 市場抑制要因
  • 免疫測定自動分析装置に関連する高コストと予算の制約
• 市場機会
  • 免疫測定自動分析装置への新技術の統合
  • 検査性能を向上させる高度な免疫測定分析装置の登場
• 市場の課題
  • 訓練を受けた経験豊富な専門家の不足

ポーターのファイブフォース：免疫測定自動分析装置市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：免疫測定自動分析装置市場における外部からの影響の把握

外部マクロ環境要因は、免疫測定自動分析装置市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析免疫測定自動分析装置市場における競合情勢の把握

免疫測定自動分析装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス免疫測定自動分析装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、免疫測定自動分析装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨免疫測定自動分析装置市場における成功への道筋を描く

免疫測定自動分析装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患や感染症の蔓延が増加
    • 臨床検査室の自動化への急速な移行
    • 早期診断と治療への意識の高まり
  • 抑制要因
    • 免疫測定自動分析装置の高コストと予算の制約
  • 機会
    • 免疫測定自動分析装置における新技術の統合
    • 研究室のパフォーマンスを向上させる高度な免疫測定分析装置の登場
  • 課題
    • 訓練を受けた経験豊富な専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 免疫測定自動分析装置市場：製品別

• 化学発光
• 酵素結合蛍光システム
• 免疫蛍光法
• 放射免疫測定

第7章 免疫測定自動分析装置市場：用途別

• アレルギー検査
• 慢性疾患
• 薬物モニタリング
• 内分泌学
• 感染症

第8章 免疫測定自動分析装置市場：エンドユーザー別

• 学術調査機関
• バイオテクノロジーおよび製薬企業
• 診断検査ラボ
• 病院

第9章 南北アメリカの免疫測定自動分析装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の免疫測定自動分析装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの免疫測定自動分析装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Arlington Scientific, Inc.
• Becton Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Biobase Biodusty（Shandong）, Co., Ltd.
• bioMerieux SA
• Carolina Liquid Chemistries Corp.
• Charles River Laboratories
• Chengdu Vacure Biotechnology Co., Ltd.
• Danaher Corporation
• F. Hoffmann-La Roche AG
• Getein Biotech, Inc.
• Hipro Biotechnology Co., Ltd.
• Hitachi, Ltd.
• Illumina, Inc.
• Laboratory Corporation of America Holdings
• Luminex Corporation by DiaSorin Company
• Medline Industries, LP
• Meril Life Sciences Pvt. Ltd.
• PerkinElmer, Inc.
• PHC Europe B.V.
• Qiagen N.V.
• Randox Laboratories
• Siemens Healthineers
• Sysmex Corporation

LIST OF FIGURES

• FIGURE 1. AUTOMATED IMMUNOASSAY ANALYZERS MARKET RESEARCH PROCESS
• FIGURE 2. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. AUTOMATED IMMUNOASSAY ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. AUTOMATED IMMUNOASSAY ANALYZERS MARKET DYNAMICS
• TABLE 7. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENZYME-LINKED FLUORESCENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ALLERGY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY DRUG MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY DIAGNOSTIC TEST LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. CANADA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. CANADA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. CANADA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. CHINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. CHINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. CHINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. INDIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. ITALY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. ITALY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. ITALY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. POLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. POLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. POLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. QATAR AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. QATAR AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. QATAR AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 151. AUTOMATED IMMUNOASSAY ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023

The Automated Immunoassay Analyzers Market was valued at USD 11.82 billion in 2023, expected to reach USD 12.63 billion in 2024, and is projected to grow at a CAGR of 6.92%, to USD 18.89 billion by 2030.

Automated Immunoassay Analyzers are sophisticated instruments designed to automate the detection and quantification of specific biomolecules or analytes within a sample through immunoassay techniques. Their necessity arises from the demand for high-throughput, accurate, and rapid diagnostic results in fields like clinical laboratories, pharmaceuticals, and biotechnology. The primary application spans disease diagnostics, drug monitoring, and cancer biomarkers detection, while key end-users include hospitals, research institutes, and diagnostic laboratories. Market growth is driven by technological advancements, rising incidences of chronic diseases, and increased adoption of automation in laboratories to improve efficiency and reduce errors. Opportunities lie in emerging markets, personalized medicine, and integration with AI for improved data interpretation. Companies can capitalize on these by fostering innovations that enhance analyzer throughput, sensitivity, and integration capabilities. However, challenges such as high initial investment costs, stringent regulations, and the need for highly skilled personnel may hinder market expansion. Intellectual property issues and competition from alternative diagnostic methods like molecular diagnostics also pose threats. The industry can benefit from innovations in assay development to broaden testing parameters, and in miniaturization of devices to cater to point-of-care settings. Moreover, research into cost-effective, multifunctional analyzers could open new avenues for market penetration. The automated immunoassay market exhibits a dynamic nature characterized by rapid technological innovation, competitive pricing, and a push for improved patient outcomes. As such, continuous engagement in R&D, strategic partnerships, and acquisition of regulatory approvals are crucial for sustaining competitive advantage. Companies should also focus on expanding their geographical footprint to emerging economies where laboratory infrastructure is evolving, offering a burgeoning consumer base with rising healthcare expenditure. By addressing these areas, businesses in the automated immunoassay sector can navigate challenges and harness opportunities for growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Automated Immunoassay Analyzers Market

The Automated Immunoassay Analyzers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of chronic and infectious diseases across the globe
  • Rapid shift towards clinical laboratory automation
  • Surging awareness of early diagnosis and treatments
• Market Restraints
  • Associated high cost of automated immunoassay analyzers and budget constraints
• Market Opportunities
  • Integration of novel technologies in automated immunoassay analyzers
  • Emergence of advanced immunoassay analyzer for enhanced laboratory performance
• Market Challenges
  • Lack of trained and experienced professionals

Porter's Five Forces: A Strategic Tool for Navigating the Automated Immunoassay Analyzers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Automated Immunoassay Analyzers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Automated Immunoassay Analyzers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Automated Immunoassay Analyzers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Automated Immunoassay Analyzers Market

A detailed market share analysis in the Automated Immunoassay Analyzers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Automated Immunoassay Analyzers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Automated Immunoassay Analyzers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Automated Immunoassay Analyzers Market

A strategic analysis of the Automated Immunoassay Analyzers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Automated Immunoassay Analyzers Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Arlington Scientific, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Biobase Biodusty(Shandong), Co., Ltd., bioMerieux SA, Carolina Liquid Chemistries Corp., Charles River Laboratories, Chengdu Vacure Biotechnology Co., Ltd., Danaher Corporation, F. Hoffmann-La Roche AG, Getein Biotech, Inc., Hipro Biotechnology Co., Ltd., Hitachi, Ltd., Illumina, Inc., Laboratory Corporation of America Holdings, Luminex Corporation by DiaSorin Company, Medline Industries, LP, Meril Life Sciences Pvt. Ltd., PerkinElmer, Inc., PHC Europe B.V., Qiagen N.V., Randox Laboratories, Siemens Healthineers, and Sysmex Corporation.

Market Segmentation & Coverage

This research report categorizes the Automated Immunoassay Analyzers Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Chemiluminescence, Enzyme-Linked Fluorescent System, Immunofluorescence, and Radioimmunoassay.
• Based on Application, market is studied across Allergy Testing, Chronic Diseases, Drug Monitoring, Endocrinology, and Infectious Diseases.
• Based on End-User, market is studied across Academic Research Institutes, Biotech & Pharma Companies, Diagnostic Test Laboratories, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of chronic and infectious diseases across the globe
    • 5.1.1.2. Rapid shift towards clinical laboratory automation
    • 5.1.1.3. Surging awareness of early diagnosis and treatments
  • 5.1.2. Restraints
    • 5.1.2.1. Associated high cost of automated immunoassay analyzers and budget constraints
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of novel technologies in automated immunoassay analyzers
    • 5.1.3.2. Emergence of advanced immunoassay analyzer for enhanced laboratory performance
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of trained and experienced professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Automated Immunoassay Analyzers Market, by Product

• 6.1. Introduction
• 6.2. Chemiluminescence
• 6.3. Enzyme-Linked Fluorescent System
• 6.4. Immunofluorescence
• 6.5. Radioimmunoassay

7. Automated Immunoassay Analyzers Market, by Application

• 7.1. Introduction
• 7.2. Allergy Testing
• 7.3. Chronic Diseases
• 7.4. Drug Monitoring
• 7.5. Endocrinology
• 7.6. Infectious Diseases

8. Automated Immunoassay Analyzers Market, by End-User

• 8.1. Introduction
• 8.2. Academic Research Institutes
• 8.3. Biotech & Pharma Companies
• 8.4. Diagnostic Test Laboratories
• 8.5. Hospitals

9. Americas Automated Immunoassay Analyzers Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Automated Immunoassay Analyzers Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Automated Immunoassay Analyzers Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Arlington Scientific, Inc.
• 3. Becton Dickinson and Company
• 4. Bio-Rad Laboratories, Inc.
• 5. Biobase Biodusty(Shandong), Co., Ltd.
• 6. bioMerieux SA
• 7. Carolina Liquid Chemistries Corp.
• 8. Charles River Laboratories
• 9. Chengdu Vacure Biotechnology Co., Ltd.
• 10. Danaher Corporation
• 11. F. Hoffmann-La Roche AG
• 12. Getein Biotech, Inc.
• 13. Hipro Biotechnology Co., Ltd.
• 14. Hitachi, Ltd.
• 15. Illumina, Inc.
• 16. Laboratory Corporation of America Holdings
• 17. Luminex Corporation by DiaSorin Company
• 18. Medline Industries, LP
• 19. Meril Life Sciences Pvt. Ltd.
• 20. PerkinElmer, Inc.
• 21. PHC Europe B.V.
• 22. Qiagen N.V.
• 23. Randox Laboratories
• 24. Siemens Healthineers
• 25. Sysmex Corporation